当前位置:首页 - 行情中心 - 威尔药业(603351) - 财务分析 - 现金流量表

威尔药业

(603351)

  

流通市值:36.14亿  总市值:36.14亿
流通股本:1.35亿   总股本:1.35亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金828,431,121.96526,557,305.31262,108,818.881,077,385,182.45
  收到的税费返还9,730,464.087,878,432.14,621,662.0513,357,336.1
  收到其他与经营活动有关的现金7,458,148.155,864,565.041,946,650.198,938,195.75
  经营活动现金流入小计845,619,734.19540,300,302.45268,677,131.121,099,680,714.3
  购买商品、接受劳务支付的现金497,021,447.24308,224,270.74165,576,856.45581,184,961.33
  支付给职工以及为职工支付的现金112,307,545.6382,961,898.8755,445,080.19136,688,805.45
  支付的各项税费57,821,472.3736,731,084.2914,492,378.7983,448,734.16
  支付其他与经营活动有关的现金34,689,071.1938,108,431.1310,951,359.7976,564,767.9
  经营活动现金流出小计701,839,536.43466,025,685.03246,465,675.22877,887,268.84
  经营活动产生的现金流量净额143,780,197.7674,274,617.4222,211,455.9221,793,445.46
二、投资活动产生的现金流量:
  收回投资收到的现金---9,273,208.54
  取得投资收益收到的现金15,380.18--203,760
  收到的其他与投资活动有关的现金900,000900,000900,000500,000
  投资活动现金流入小计915,380.18900,000900,0009,976,968.54
  购建固定资产、无形资产和其他长期资产支付的现金49,482,846.9739,197,235.0819,925,198.8351,457,885.1
  投资支付的现金33,000,00033,000,00030,000,00027,800,000
  支付其他与投资活动有关的现金600,000600,000600,0001,200,000
  投资活动现金流出小计83,082,846.9772,797,235.0850,525,198.8380,457,885.1
  投资活动产生的现金流量净额-82,167,466.79-71,897,235.08-49,625,198.83-70,480,916.56
三、筹资活动产生的现金流量:
  取得借款收到的现金421,000,000309,000,000121,000,000381,020,400
  筹资活动现金流入小计421,000,000309,000,000121,000,000381,020,400
  偿还债务支付的现金291,800,000239,800,00091,300,000378,300,000
  分配股利、利润或偿付利息支付的现金62,127,676.8960,027,865.222,757,064.0955,466,885.36
  支付其他与筹资活动有关的现金8,538,580.854,825,434.933,338,664.0810,285,349.43
  筹资活动现金流出小计362,466,257.74304,653,300.1597,395,728.17444,052,234.79
  筹资活动产生的现金流量净额58,533,742.264,346,699.8523,604,271.83-63,031,834.79
四、汇率变动对现金及现金等价物的影响780.95342,762.81-2,456.451,373,441.63
五、现金及现金等价物净增加额120,147,254.187,066,845-3,811,927.5589,654,135.74
  加:期初现金及现金等价物余额247,200,482.38247,200,482.38247,200,482.38157,546,346.64
  期末现金及现金等价物余额367,347,736.56254,267,327.38243,388,554.83247,200,482.38
补充资料:
  净利润-71,302,630.46-145,205,838.7
  资产减值准备-2,467,637.19-9,014,547.81
  固定资产和投资性房地产折旧-59,616,498.13-102,706,888.04
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-59,616,498.13-102,706,888.04
  无形资产摊销-2,423,086.46-4,659,431.49
  长期待摊费用摊销-36,334.29-86,969.87
  处置固定资产、无形资产和其他长期资产的损失--6,484.57--
  固定资产报废损失-90,420.98-168,218.5
  公允价值变动损失--1,736.22--12,072,961.13
  财务费用-5,613,022.4-12,464,017.03
  投资损失---68,939.98
  递延所得税-949,858.45-5,088,725.2
  其中:递延所得税资产减少-451,587.74-1,170,114.06
    递延所得税负债增加-498,270.71-3,918,611.14
  存货的减少--11,785,019.22--40,461,738.19
  经营性应收项目的减少--78,285,739.97--13,566,041.63
  经营性应付项目的增加-16,663,396.16--3,983,056.8
  其他---3,357,643.89
  不涉及现金收支的投资和筹资活动金额其他项目---24,771,652.06
  现金的期末余额-254,267,327.38-247,200,482.38
  减:现金的期初余额-247,200,482.38-157,546,346.64
  现金及现金等价物的净增加额-7,066,845-89,654,135.74
公告日期2025-10-302025-08-202025-04-222025-04-22
审计意见(境内)标准无保留意见
TOP↑